Literature DB >> 10069014

Arthritogenicity of Yersinia enterocolitica O:8 in hamsters: analysis of the immune response.

M S Di Genaro1, M E Escudero, E Muñoz, C Aguilera, A Juarez, L Scardapane, A M de Guzmán.   

Abstract

An animal model, hamster, was used for the study of Yersinia-induced arthritis. The development of arthritis, estimated by measuring the inflammation on hind paws after infection, was correlated with the kinetics of the immune response. Histological and immunofluorescence (IFI) studies and serum antibody measurements were performed. Two inflammatory peaks were observed: an acute one on day 11 post-infection (p.i.) and a chronic one on days 26-35 p.i. Joint cultures were positive until day 14 p.i. IFI was used to demonstrate the deposit of bacterial antigens in the joint. A persistent response of cellular extract-specific IgG antibodies was observed until day 94. Lipopolysaccharide-specific IgG was statistically significant on day 26 p.i. Antibodies against bands 66 and 54 were observed by immunoblotting. Polyclonal activation was detected during reactive arthritis. It is shown that Y. enterocolitica is arthritogenic in hamsters, immune mechanisms participating in the development of this disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10069014     DOI: 10.1007/bf02816392

Source DB:  PubMed          Journal:  Folia Microbiol (Praha)        ISSN: 0015-5632            Impact factor:   2.099


  15 in total

1.  Yersinia-triggered reactive arthritis. Use of polymerase chain reaction and immunocytochemical staining in the detection of bacterial components from synovial specimens.

Authors:  S Nikkari; R Merilahti-Palo; R Saario; K O Söderström; K Granfors; M Skurnik; P Toivanen
Journal:  Arthritis Rheum       Date:  1992-06

2.  Presence of autoantibodies in the serum of mice infected with Yersinia enterocolitica O:3.

Authors:  D P Falcão; B M de Medieros; A de Moraes Costa; P M de Araújo
Journal:  Contrib Microbiol Immunol       Date:  1995

Review 3.  Role of endogenous enteric organisms in the reactivation of arthritis.

Authors:  S N Lichtman
Journal:  Mol Med Today       Date:  1995-11

4.  Experimental Yersinia enterocolitica infection in rats: analysis of the immune response to plasmid-encoded antigens of arthritis-susceptible Lewis rats and arthritis-resistant Fischer rats.

Authors:  K Gaede; D Mack; J Heesemann
Journal:  Med Microbiol Immunol       Date:  1992       Impact factor: 3.402

5.  Synovial fluid-derived Yersinia-reactive T cells responding to human 65-kDa heat-shock protein and heat-stressed antigen-presenting cells.

Authors:  E Hermann; A W Lohse; R Van der Zee; W Van Eden; W J Mayet; P Probst; T Poralla; K H Meyer zum Büschenfelde; B Fleischer
Journal:  Eur J Immunol       Date:  1991-09       Impact factor: 5.532

6.  Treatment of arthritis in Lewis rats by a monoclonal antibody against alpha beta T cell receptor: differential sensitivity of Yersinia-induced arthritis versus adjuvant arthritis.

Authors:  K Gaede; M Nazet; D Bosse; J Heesemann
Journal:  Clin Immunol Immunopathol       Date:  1995-12

7.  Development of an experimental animal model for reactive arthritis induced by Yersinia enterocolitica infection.

Authors:  J L Hill; D T Yu
Journal:  Infect Immun       Date:  1987-03       Impact factor: 3.441

Review 8.  Yersinia enterocolitica lipopolysaccharide: genetics and virulence.

Authors:  M Skurnik; P Toivanen
Journal:  Trends Microbiol       Date:  1993-07       Impact factor: 17.079

9.  Role of YadA-mediated collagen binding in arthritogenicity of Yersinia enterocolitica serotype O:8: experimental studies with rats.

Authors:  C Gripenberg-Lerche; M Skurnik; P Toivanen
Journal:  Infect Immun       Date:  1995-08       Impact factor: 3.441

10.  Development of destructive arthritis in vaccinated hamsters challenged with Borrelia burgdorferi.

Authors:  L C Lim; D M England; B K DuChateau; N J Glowacki; J R Creson; S D Lovrich; S M Callister; D A Jobe; R F Schell
Journal:  Infect Immun       Date:  1994-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.